HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Dimethyl Sulfoxide → [4-((R)-2-formyl-6-oxo-piperidin-1-yl)-butoxy]-acetic acid ethyl ester

HRID 2052950
Print

Reaction equation

HRID 2052950 reaction equation
CS(C)=O.[CH2:5]([O:7][C:8](=[O:24])[CH2:9][O:10][CH2:11][CH2:12][CH2:13][CH2:14][N:15]1[C:20](=[O:21])[CH2:19][CH2:18][CH2:17][C@@H:16]1[CH2:22][OH:23])[CH3:6].FC(F)(F)C([O-])=O.[NH+]1C=CC=CC=1>C1C=CC=CC=1>[CH2:5]([O:7][C:8](=[O:24])[CH2:9][O:10][CH2:11][CH2:12][CH2:13][CH2:14][N:15]1[C:20](=[O:21])[CH2:19][CH2:18][CH2:17][C@@H:16]1[CH:22]=[O:23])[CH3:6]
ParticipantsConditionsProcedureWorkupSources & evidenceReaction notes

Participants

5

Reactant 3

HCID 679Dimethyl SulfoxideHCID 9813011pyridine TFAHCID 69020752[4-((R)-2-hydroxymethyl-6-oxo-piperidin-1-yl)-butoxy]-acetic acid ethyl ester

Product 1

HCID 86595299[4-((R)-2-formyl-6-oxo-piperidin-1-yl)-butoxy]-acetic acid ethyl ester

Reagents, catalysts & solvents 1

HCID 241BenzeneSolvent

Conditions

Temperature
0 °C

Procedure

1-(3-(Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI, 505 mg, 2.63 mmol) and DMSO (0.25 mL, 3.52 mmol) were added sequentially to a solution of [4-((R)-2-hydroxymethyl-6-oxo-piperidin-1-yl)-butoxy]-acetic acid ethyl ester (252 mg, 0.88 mmol) in benzene (5 mL). The mixture was cooled to 0° C. and pyridinium trifluoroacetate (187 mg, 0.97 mmol) was added. The reaction was allowed to warm to rt and then was stirred at rt for 4.25 h. The solution was decanted from the oily residue and the residue was washed with benzene (3×5 mL). The combined benzene phases were concentrated in vacuo to afford crude 4-((R)-2-formyl-6-oxo-piperidin-1-yl)-butoxy]-acetic acid ethyl ester that was used without further purification.

Workup

  1. temperatureto warm to rt
  2. customThe solution was decanted from the oily residue
  3. washthe residue was washed with benzene (3×5 mL)
  4. concentrationThe combined benzene phases were concentrated in vacuo
  5. customto afford crude 4-((R)-2-formyl-6-oxo-piperidin-1-yl)-butoxy]-acetic acid ethyl ester that
  6. customwas used without further purification

Sources & evidence

ORD record
ord-0e55496a6600460492f54590eb192606
Source dataset
uspto-grants-2008_02
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07326716B2

Reaction notes

On this pageParticipantsConditionsProcedureWorkupSources & evidenceReaction notes